The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
Open accessAbstract
Only a few autoantibodies that are more or less specific for RA have been described so far. The rheumatoid factor most often tested for is not very specific for RA, while the more specific antiperinuclear factor for several reasons is not routinely used as a serological parameter. Here we show that autoantibodies reactive with synthetic peptides containing the unusual amino acid citrulline, a posttranslationally modified arginine residue, are specifically present in the sera of RA patients. Using several citrulline-containing peptide variants in ELISA, antibodies could be detected in 76% of RA sera with a specificity of 96%. Sera showed a remarkable variety in the reactivity pattern towards different citrulline-containing peptides. Affinity-purified antibodies were shown to be positive in the immunofluorescence-based antiperinuclear factor test, and in the so-called antikeratin antibody test, and were reactive towards filaggrin extracted from human epidermis. The specific nature of these antibodies and the presence of these antibodies early in disease, even before other disease manifestations occur, are indicative for a possible role of citrulline-containing epitopes in the pathogenesis of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Antibodies: A laboratory manual
J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,089
Garnier, J., Osguthorpe, D. J., & Robson, B. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90297-8 · Cited by 4,523
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599
Boers, M., Verhoeven, A. C., Markusse, H. M., van de Laar, M. A., Westhovens, R., van Denderen, J. C., van Zeben, D., Dijkmans, B. A., Peeters, A. J., Jacobs, P., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01300-7 · Cited by 1,073
The antigenic index: a novel algorithm for predicting antigenic determinants
Jameson, B. A., & Wolf, H. (1988) · Bioinformatics · doi:10.1093/bioinformatics/4.1.181 · Cited by 647
New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear Factor
Nienhuis, R. L. F., Mandema, E., & Smids, C. (1964) · Annals of the Rheumatic Diseases · doi:10.1136/ard.23.4.302 · Cited by 367
Protein Unfolding by Peptidylarginine Deiminase
Tarcsa, E., Marekov, L. N., Mei, G., Melino, G., Lee, S.-C., & Steinert, P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30709 · Cited by 350
Sebbag, M., Simon, M., Vincent, C., Masson-Bessière, C., Girbal, E., Durieux, J. J., & Serre, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117969 · Cited by 344
Cited by
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J., van der Horst‐Bruinsma, I. E., de Koning, M. H. M. T., Habibuw, M. R., Vandenbroucke, J. P., & Dijkmans, B. A. C. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20018 · Cited by 1,861
Schellekens, G. A., Visser, H., De Jong, B. A. W., Van Den Hoogen, F. H. J., Hazes, J. M. W., Breedveld, F. C., & Van Venrooij, W. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<155::aid-anr20>3.0.co;2-3 · Cited by 1,450
Self-citationSuzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1206 · Cited by 1,168
Coeliac disease: dissecting a complex inflammatory disorder
Sollid, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri885 · Cited by 964
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Nishimura, K., Sugiyama, D., Kogata, Y., Tsuji, G., Nakazawa, T., Kawano, S., Saigo, K., Morinobu, A., Koshiba, M., Kuntz, K. M., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00008 · Cited by 873
Klareskog, L., Catrina, A. I., & Paget, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60008-8 · Cited by 787
Masson-Bessière, C., Sebbag, M., Girbal-Neuhauser, E., Nogueira, L., Vincent, C., Senshu, T., & Serre, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4177 · Cited by 643
van Gaalen, F. A., Linn‐Rasker, S. P., van Venrooij, W. J., de Jong, B. A., Breedveld, F. C., Verweij, C. L., Toes, R. E. M., & Huizinga, T. W. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20044 · Cited by 639
Self-citationKroot, E.-J. J. A., De Jong, B. A. W., Van Leeuwen, M. A., Swinkels, H., Van Den Hoogen, F. H. J., Van 't Hof, M., Van De Putte, L. B. A., Van Rijswijk, M. H., Van Venrooij, W. J., & Van Riel, P. L. C. M. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1831::aid-anr19>3.0.co;2-6 · Cited by 633
Self-citationShi, J., Knevel, R., Suwannalai, P., van der Linden, M. P., Janssen, G. M. C., van Veelen, P. A., Levarht, N. E. W., van der Helm-van Mil, A. H. M., Cerami, A., Huizinga, T. W. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114465108 · Cited by 595
Therapeutic Strategies for Rheumatoid Arthritis
O'Dell, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040226 · Cited by 588
Konig, M. F., Abusleme, L., Reinholdt, J., Palmer, R. J., Teles, R. P., Sampson, K., Rosen, A., Nigrovic, P. A., Sokolove, J., Giles, J. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaj1921 · Cited by 588
Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction
Crenn, P., Messing, B., & Cynober, L. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.02.005 · Cited by 586
Humby, F., Bombardieri, M., Manzo, A., Kelly, S., Blades, M. C., Kirkham, B., Spencer, J., & Pitzalis, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.0060001 · Cited by 537
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis
Kuhn, K. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25422 · Cited by 534
Avouac, J., Gossec, L., & Dougados, M. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.051391 · Cited by 486
Girbal-Neuhauser, E., Durieux, J.-J., Arnaud, M., Dalbon, P., Sebbag, M., Vincent, C., Simon, M., Senshu, T., Masson-Bessière, C., Jolivet-Reynaud, C., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.585 · Cited by 485
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Wegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmström, V., Feldmann, M., & Venables, P. J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00850.x · Cited by 471
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 467
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
Klareskog, L., Rönnelid, J., Lundberg, K., Padyukov, L., & Alfredsson, L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090244 · Cited by 463
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Vossenaar, E. R., Després, N., Lapointe, E., van der Heijden, A., Lora, M., Senshu, T., van Venrooij, W. J., & Ménard, H. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1149 · Cited by 463
Self-citationMeyer, O., Labarre, C., Dougados, M., Goupille, P., Cantagrel, A., Dubois, A., Nicaise-Roland, P., Sibilia, J., & Combe, B. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.120 · Cited by 456
Vossenaar, E. R., Radstake, T. R. D., van der Heijden, A., van Mansum, M. A. M., Dieteren, C., de Rooij, D.-J., Barrera, P., Zendman, A. J. W., & van Venrooij, W. J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012211 · Cited by 455
Self-citationThe immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Malmström, V., Catrina, A. I., & Klareskog, L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.124 · Cited by 451
Forslind, K., Ahlmén, M., Eberhardt, K., Hafström, I., & Svensson, B. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014233 · Cited by 445
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis
Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.010 · Cited by 418
Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction
Holers, V. M., Demoruelle, M. K., Kuhn, K. A., Buckner, J. H., Robinson, W. H., Okamoto, Y., Norris, J. M., & Deane, K. D. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0070-0 · Cited by 417
Kastbom, A., Strandberg, G., Lindroos, A., & Skogh, T. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016808 · Cited by 399
An overview of autoantibodies in rheumatoid arthritis
van Delft, M. A. M., & Huizinga, T. W. J. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102392 · Cited by 398
Van Gaalen, F. A., Van Aken, J., Huizinga, T. W. J., Schreuder, G. M. T., Breedveld, F. C., Zanelli, E., Van Venrooij, W. J., Verweij, C. L., Toes, R. E. M., & De Vries, R. R. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20316 · Cited by 393
Self-citationLundberg, K., Kinloch, A., Fisher, B. A., Wegner, N., Wait, R., Charles, P., Mikuls, T. R., & Venables, P. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23936 · Cited by 389
Foulquier, C., Sebbag, M., Clavel, C., Chapuy‐Regaud, S., Al Badine, R., Méchin, M., Vincent, C., Nachat, R., Yamada, M., Takahara, H., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22983 · Cited by 384
Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes
Nakashima, K., Hagiwara, T., & Yamada, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208795200 · Cited by 379
Rosenstein, E. D., Greenwald, R. A., Kushner, L. J., & Weissmann, G. (2004) · Inflammation · doi:10.1007/s10753-004-6641-z · Cited by 374
Prognostic laboratory markers of joint damage in rheumatoid arthritis
Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegård, D., & Saxne, T. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019992 · Cited by 367
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
Nell, V. P. K., Machold, K. P., Stamm, T. A., Eberl, G., Heinzl, H., Uffmann, M., Smolen, J. S., & Steiner, G. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.035691 · Cited by 354
Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis
Kinloch, A., Tatzer, V., Wait, R., Peston, D., Lundberg, K., Donatien, P., Moyes, D., Taylor, P. C., & Venables, P. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1845 · Cited by 351
Ishigaki, K., Sakaue, S., Terao, C., Luo, Y., Sonehara, K., Yamaguchi, K., Amariuta, T., Too, C. L., Laufer, V. A., Scott, I. C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01213-w · Cited by 341
Anti-CCP antibodies: the past, the present and the future
van Venrooij, W. J., van Beers, J. J. B. C., & Pruijn, G. J. M. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.76 · Cited by 341
Self-citationDe Rycke, L., Peene, I., Hoffman, I. E. A., Kruithof, E., Union, A., Meheus, L., Lebeer, K., Wyns, B., Vincent, C., Mielants, H., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017574 · Cited by 341
Oxidative stress in autoimmune rheumatic diseases
Smallwood, M. J., Nissim, A., Knight, A. R., Whiteman, M., Haigh, R., & Winyard, P. G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.086 · Cited by 336
Impaired early B cell tolerance in patients with rheumatoid arthritis
Samuels, J., Ng, Y.-S., Coupillaud, C., Paget, D., & Meffre, E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042321 · Cited by 328
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
Tissue-mediated control of immunopathology in coeliac disease
Jabri, B., & Sollid, L. M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2670 · Cited by 307
Clinical utility of the anti-CCP assay in patients with rheumatic diseases
Lee, D. M., & Schur, P. H. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.870 · Cited by 295
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
Bang, H., Egerer, K., Gauliard, A., Lüthke, K., Rudolph, P. E., Fredenhagen, G., Berg, W., Feist, E., & Burmester, G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22817 · Cited by 293
Luo, Y., Arita, K., Bhatia, M., Knuckley, B., Lee, Y.-H., Stallcup, M. R., Sato, M., & Thompson, P. R. (2006) · Biochemistry · doi:10.1021/bi061180d · Cited by 290
Willis, V. C., Gizinski, A. M., Banda, N. K., Causey, C. P., Knuckley, B., Cordova, K. N., Luo, Y., Levitt, B., Glogowska, M., Chandra, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001620 · Cited by 287
Brahms, H., Raymackers, J., Union, A., de Keyser, F., Meheus, L., & Lührmann, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000300200 · Cited by 285
Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses
Fousert, E., Toes, R., & Desai, J. (2020) · Cells · doi:10.3390/cells9040915 · Cited by 282
Diagnostic Accuracy of the Anti-Citrulline Antibody Assay for Rheumatoid Arthritis
Bizzaro, N., Mazzanti, G., Tonutti, E., Villalta, D., & Tozzoli, R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.6.1089 · Cited by 282
Hill, J. A., Bell, D. A., Brintnell, W., Yue, D., Wehrli, B., Jevnikar, A. M., Lee, D. M., Hueber, W., Robinson, W. H., & Cairns, E. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072051 · Cited by 275
Bos, W. H., Wolbink, G. J., Boers, M., Tijhuis, G. J., de Vries, N., van der Horst-Bruinsma, I. E., Tak, P. P., van de Stadt, R. J., van der Laken, C. J., Dijkmans, B. A. C., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105759 · Cited by 274
Mikuls, T. R., Payne, J. B., Reinhardt, R. A., Thiele, G. M., Maziarz, E., Cannella, A. C., Holers, V. M., Kuhn, K. A., & O'Dell, J. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.09.008 · Cited by 271
Antigen microarray profiling of autoantibodies in rheumatoid arthritis
Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J., Bruce, B., Fries, J. F., Sønderstrup, G., Monach, P., Drijfhout, J. W., van Venrooij, W. J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21269 · Cited by 261
Self-citationWigerblad, G., Bas, D. B., Fernades-Cerqueira, C., Krishnamurthy, A., Nandakumar, K. S., Rogoz, K., Kato, J., Sandor, K., Su, J., Jimenez–Andrade, J. M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208094 · Cited by 260
The presence of citrullinated proteins is not specific for rheumatoid synovial tissue
Vossenaar, E. R., Smeets, T. J. M., Kraan, M. C., Raats, J. M., Van Venrooij, W. J., & Tak, P. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20584 · Cited by 256
Self-citationAnti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis
Aggarwal, R., Liao, K., Nair, R., Ringold, S., & Costenbander, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24827 · Cited by 253
Kriebel, K., Hieke, C., Müller-Hilke, B., Nakata, M., & Kreikemeyer, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00053 · Cited by 118
“While citrullination itself is a physiological process, the formation of antibodies against citrullinated peptide antigens is highly specific for RA (Schellekens et al., 1998).”
BackgroundRyan, B. J., Nissim, A., & Winyard, P. G. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.004 · Cited by 119
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Meroni, P. L., Biggioggero, M., Pierangeli, S. S., Sheldon, J., Zegers, I., & Borghi, M. O. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.180 · Cited by 92
Rebak, A. S., Hendriks, I. A., Elsborg, J. D., Buch-Larsen, S. C., Nielsen, C. H., Terslev, L., Kirsch, R., Damgaard, D., Doncheva, N. T., Lennartsson, C., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01214-9 · Cited by 45
Metadata
- Authors
- Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-01-01
- Volume
- 101
- Issue
- 1
- Pages
- 273-281
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2109578241
- Cited by
- 1,450
- References
- 21
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.